Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Translational Medicine and Pharmacology TMP, Theodo, Frankfurt am Main, Germany
Ceramides as Novel Disease Biomarkers.
Ceramides are sphingolipids and integral components of the eukaryotic cell membrane. Apart from providing structural integrity, ceramides have also been shown to act as second messengers in cell signaling processes. In recent publications, ceramide modulation has been reported in pathological conditions such as cancer, diabetes, Alzheimer's disease (AD), coronary artery disease (CAD), multiple sclerosis (MS), as well as depression. Ceramides or ceramide panel combinations have been proposed as specific disease biomarkers that could be detected in diseased tissue, synovial fluid, cerebrospinal fluid (CSF), and blood. This article reviews ceramide modulation in a selection of different diseases and the potential use of ceramides as biomarkers in diagnostics, determination of disease stage and personalized medicine.
- Similar Topics
- Last post
Angiogenesis, fingolimod and ceramides
Last post by frodo « Thu Apr 19, 2018 11:19 pm
Posted in Chronic Cerebrospinal Venous Insufficiency (CCSVI)by frodo » Thu Apr 19, 2018 11:19 pm » in Chronic Cerebrospinal Venous Insufficiency (CCSVI)
- 0 Replies
- 1131 Views
Last post by frodo
Thu Apr 19, 2018 11:19 pm